Dynavax Technologies Balance Sheet Health
Financial Health criteria checks 6/6
Dynavax Technologies has a total shareholder equity of $622.1M and total debt of $222.7M, which brings its debt-to-equity ratio to 35.8%. Its total assets and total liabilities are $997.1M and $375.0M respectively.
Key information
35.8%
Debt to equity ratio
US$222.70m
Debt
Interest coverage ratio | n/a |
Cash | US$742.30m |
Equity | US$622.07m |
Total liabilities | US$375.02m |
Total assets | US$997.10m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0IDA's short term assets ($859.1M) exceed its short term liabilities ($62.2M).
Long Term Liabilities: 0IDA's short term assets ($859.1M) exceed its long term liabilities ($312.8M).
Debt to Equity History and Analysis
Debt Level: 0IDA has more cash than its total debt.
Reducing Debt: 0IDA's debt to equity ratio has reduced from 159.9% to 35.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 0IDA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 0IDA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 46.2% per year.